Fragile X Syndrome
Advancing Research for Patients With Fragile X Syndrome
Learn more about clinical trials for Fragile X syndrome
By clicking this link, you will be redirected to a third-party site. Shionogi does not control, endorse, or influence the content. The site you are about to visit is governed by its own Terms & Conditions and Privacy Policy.
The link you clicked will take you to a separate site maintained by Shionogi Inc.
The link you clicked will take you to a separate site maintained by another Shionogi Group Company, Shionogi & Co., Ltd., which is headquartered in Japan.
Medical practices and regulations can be different from one country to another. As a result, the medical information provided in the site which you are going to visit may not be appropriate for product use in your country.
Please note that the Privacy Policy and Terms of Use may vary on different country sites within the Shionogi Group.
This site is intended to help healthcare professionals in the United States and its territories find scientifically balanced information related to Shionogi products, including clinical data and research developments. The site is made available by Shionogi's U.S. Medical Affairs organization, and is provided as a scientific resource for informational, non-promotional purposes.
This site may contain information about products or uses that have not been approved by the U.S. Food and Drug Administration. Shionogi does not recommend the use of its products other than as described in the approved prescribing information. The content of this site is not medical advice and does not replace independent medical judgment. Healthcare providers are responsible for individual patient care on the basis of their professional knowledge and experience.
Choose the option that best describes you.